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OBJECTIVES Our objective was to determine the prognostic value of estimated metabolic equivalents
(METs) based on self-reported functional capacity by the Duke Activity Status Index (DASI)
in symptomatic women.
BACKGROUND Functional capacity is an important component affecting the predictive value of exercise
testing, yet current guidelines offer limited assistance regarding identification of functional
impairment and choice of pharmacologic stress testing.
METHODS A total of 914 women underwent clinically indicated coronary angiography and completed the
12-item DASI questionnaire; a subgroup of 251 women also underwent exercise testing. Cox
proportional hazards modeling was used to estimate five-year death or myocardial infarction
by DASI scores. In a secondary analysis, additional events included unstable angina, heart
failure, or stroke at five years.
RESULTS Average DASI-estimated functional capacity was 5.7  4.2 METs and, for exercising
women, 6.0  2.6 METs. In the 914 women, event-free survival ranged from 83% to 95%
in subgroups with 4.7 to 9.9 METs (p  0.009); 67% of the events occurred in women
scoring 4.7 METs (p  0.003). Event rates were similar by exercise and DASI MET
values. In women with DASI-estimated METs 4.7 (n  75), ischemia occurred less (39%
vs. 64%, p  0.0001), and exercise testing results were more often indeterminate (85%
predicted maximum heart rate  37% vs. 6%, p  0.001) as compared to women achieving
4.7 METs.
CONCLUSIONS Among women with suspected myocardial ischemia, functional impairment estimated by the
DASI correlates with indeterminate exercise test results and is associated with an adverse
prognosis. Use of the DASI before exercise testing can risk stratify symptomatic women and
may improve the identification of higher-risk, functionally impaired subjects that would
benefit from pharmacologic stress imaging and targeted risk management. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.03.080Cardiol 2006;47:36S–43S) © 2006 by the American College of Cardiology Foundation
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Ahe exercise electrocardiogram has been reported to have a
ower diagnostic accuracy in women (1,2). While a number
f factors may contribute to this, the lower diagnostic
ccuracy of the exercise electrocardiogram is, in part, related
o the fact that women have higher rates of functional
mpairment leading to a diminished exercise capacity, an
nability to attain maximal stress, and to provoke ischemia
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esting are candidates for pharmacologic stress testing,
lthough current guidelines offer limited assistance with
egard to the methods of recognition and identification of
unctionally impaired subsets of the population (4).
Maximal predicted heart rate, oxygen consumption, and,
ore commonly, metabolic equivalents (METs) are mea-
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February 7, 2006:36S–43S Functional Disability in Symptomatic Womenures used to estimate physical work capacity. Recent studies
emonstrate that the estimation of MET capacity may be
sed for prognostication in women (5,6). The Duke Activity
tatus Index (DASI) is a simple 12-item questionnaire that
omputes functional capabilities based upon activities of
aily living and recreational activities and is a validated
stimator of maximal oxygen consumption (7). Despite the
ase with which the questionnaire can be measured and its
alidation specifically in women (8), the DASI has not been
valuated with regards to prognosis or compared to exercise
esting results in a large cohort of women.
The purpose of the current analysis was to evaluate and
ompare the prognostic value of estimated METs as deter-
ined from the DASI in a cohort of 914 women with
uspected myocardial ischemia and angiographically defined
oronary disease, a subset of whom also underwent exercise
tress testing (n  251).
ETHODS
atient entry criteria. The Women’s Ischemia Syndrome
valuation (WISE) is a four-center study aiming to im-
rove diagnostic testing strategies and advance new hypoth-
ses related to the pathophysiology of cardiovascular disease
n women (9). The study cohort consisted of 914 women (of
,603 women screened) presenting with suspected myocar-
ial ischemia that underwent diagnostic coronary angiogra-
hy and were enrolled in the National Institutes of Health-
ational Heart, Lung, and Blood Institute-sponsored
ISE study. Before enrollment, all women were referred
or a clinically indicated coronary angiogram with diagnostic
esting being performed after catheterization. Women en-
olled in the WISE study underwent a battery of non-
nvasive and invasive diagnostic tests in order to identify an
mproved strategy for the detection of coronary artery
isease. Exercise stress testing was performed only at the
niversity of Florida and, as such, MET values and their
ssociated prognosis could be compared in a subset of 251
omen that also underwent graded treadmill stress testing.
aseline evaluations. Initial evaluation included the col-
ection of demographic, medical history, and symptom data.
ubjects also underwent a physical examination that in-
luded blood pressure and physical measurements. The
omplete design and methodology of the WISE study are
escribed elsewhere (9). However, in brief, in response to
he National Institutes of Health proposal, each individual
enter devised its own diagnostic armamentarium, but a
ore of historical (e.g., vascular disease history), angio-
raphic (i.e.,50% stenosis), symptom (e.g., typical angina)
Abbreviations and Acronyms
DASI  Duke Activity Status Index
METs  metabolic equivalents
WISE  Women’s Ischemia Syndrome Evaluationrofile, and quality-of-life parameters were collected at easeline (Table 1). The DASI was part of the quality-of-life
easurements that were collected on all women.
oronary angiography core laboratory. All angiograms
ere quantitatively evaluated by an independent WISE
ngiographic core laboratory (10). Angiograms were inter-
reted blinded to the patient’s clinical history. Obstructive
oronary disease was defined quantitatively as 50% steno-
is in 1 epicardial coronary artery (10). The number of
iseased vessels was then scored.
xercise testing procedures. Treadmill exercise testing
as performed using the modified or Bruce (n  165) or
symptomatic Cardiac Ischemia Pilot (n  86) protocols.
tandards for the conductance of testing and termination of
xercise were consistent with the current American College
f Cardiology/American Heart Association guidelines for
xercise testing (4). Generally, patients exercised until the
oint of volitional fatigue unless marked electrocardio-
raphic abnormalities, hemodynamic instability, chrono-
ropic incompetence, ventricular tachycardia or fibrillation,
r disabling chest pain symptoms occurred.
unctional status measures. Patients completed the
ASI at baseline before exercise testing (7). The DASI is a
imple, easily administered, 12-item quality-of-life instru-
ent that provides a patient’s self-assessment of her func-
ional capabilities. Original development of the DASI was
orrelated and validated to estimate maximal oxygen con-
umption measurements at peak exercise (7). Using an
stimation of maximal oxygen consumption, METs were
alculated by dividing by 3.5. We categorized the DASI
ased upon MET values for stages of the commonly applied
ruce protocol including 1 to 4.7, 4.8 to 7.4, 7.5 to 9.9, and
9.9 METs. (See the Appendix for a copy of the DASI
uestionnaire and scoring, in METs.) We have previously
alidated the DASI in the WISE study population for the
stimation of exercise stress test METs (8).
ollow-up procedures. Each patient gave informed con-
ent and was enrolled in the follow-up portion of this study.
ach center had institutional review board approval for the
nclusion of patients in this registry as well as for the
ollection of follow-up data. Patients were contacted at six
eeks and at one-year intervals after their initial enrollment.
uring the telephone contact, an experienced nurse or
hysician completed a scripted interview. At the time of
his interview, each patient or a family member was queried
or the occurrence of major adverse cardiac events or
ospitalizations.
The primary end point for this analysis was five-year
eath or non-fatal myocardial infarction. Due to the smaller
ample size of the exercising cohort (n  251), a secondary
nalysis included other major adverse events including
ospitalization for congestive heart failure or unstable an-
ina. In the event that a major adverse cardiac event was
dentified, the referring investigator was contacted for for-
ation dates and documentation of the occurrence. In the
vent of death, a death certificate was requested. An
xperienced investigator blinded to the clinical and stress
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Functional Disability in Symptomatic Women February 7, 2006:36S–43Sest data collected this confirmation. Follow-up was com-
lete in 95% of patients.
tatistical analysis. Continuous variables were expressed
s means  SD. General linear models or analysis of
ariance techniques were used to compare continuous mea-
ures by DASI and exercise MET categories. Categorical
ariables were recorded as frequencies and compared by
hi-square statistic or Fisher exact test. A Fisher exact test
as computed for tables containing cells with an expected
requency of 5. A value of p  0.05 was considered
tatistically significant.
The primary end point for this prognostic analysis was
ime to death or non-fatal myocardial infarction for the
14 patients. Using a post-hoc sample size calculation,
alpha  0.05, two-tailed), statistical power exceeded
Table 1. Clinical Characteristics* of the 914 P
Ischemia Syndrome Evaluation (WISE)
% or Mean  SD Values
(Where Indicated)
E
Age (yrs)
Postmenopausal
Body mass index
30 kg/m2
Chest pain
Nonanginal
Atypical
Typical
Cardiac risk factors
Hypertension
Current smoker
Diabetes
Insulin-dependent
Hypercholesterolemia
Coronary disease extent
No stenosis 50%
1-vessel coronary disease
2-vessel coronary disease
3-vessel coronary disease
Exercise test results
Total exercise time (min)
Peak METs
4.7 METs
4.8–7.4 METs
7.5–9.9 METs
9.9 METs
Peak heart rate (beats/min)
85% predicted maximum heart rate
Peak systolic blood pressure (mm Hg)
Exertional chest pain
ST-segment depression 1.0 mm
Number of abnormal leads
Maximal ST-segment depression (mm)
DASI score
1–4.7 METs
4.8–7.4 METs
7.5–9.9 METs
9.9 METs
*All values are % except where indicated as mean SD for ag
peak heart rate, peak systolic blood pressure, number of abn
DASI  Duke Activity Status Index; METs  metabol.80 for a comparison of differences in event-free survival wased on a sample size of 914 women. For validation of
he DASI’s prognostic value, a secondary analysis in a
maller cohort of 251 exercising women evaluated time to
eath, stroke, congestive heart failure, myocardial infarc-
ion, or unstable angina. Cox proportional hazards mod-
ls were used to assess time to cardiac events by the DASI
nd exercise MET estimates using subsets of 1 to 4.7, 4.8
o 7.4, 7.5 to 9.9, and 9.9; as noted previously, these
ET groupings were chosen to correlate with the
tandard Bruce protocol exercise stress testing stages.
rom the Cox model, five-year event-free survival was
alculated for each of the DASI subsets. From the Cox
roportional hazards model, the relative risk ratio and
5% confidence intervals were calculated. Additionally, in
he exercising subset of patients, predicted event rates
t Study Cohort Enrolled in the Women’s
omen Undergoing
se Testing and DASI
(n  251)
Women With DASI
Measurement
(n  914)
56.3  10 58.2  12
70% 72%
30  7 30  7
43% 40%
35% 34%
29% 36%
36% 30%
48% 59%
22% 20%
17% 25%
8% 12%
43% 50%
68% 60%
12% 16%
12% 10%
8% 14%
5.7  3 n/a
6.0  3
30%
45%
14%
12%
144  21
64%
168  27
27%
41%
1.9  3
0.7  0.9
43% 52%
20% 18%
17% 11%
20% 19%
y mass index, total exercise time, peak metabolic equivalents,
leads, and maximal ST-segment depression.
valents; n/a  not applicable.atien
W
xerci
e, bodere calculated from two separate univariable Cox mod-
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hroughout follow-up. A p value was calculated based
pon the predictive value of each univariable Cox model.
inally, a risk-adjusted model was devised to evaluate the
ndependent contribution of the DASI MET values
hen controlling for important clinical characteristics
ncluding age, body mass index, diabetes, hypertension,
yperlipidemia, history of coronary disease, and the
xtent of coronary disease at angiography.
ESULTS
linical characteristics of the WISE study cohort.
omen completing the DASI questionnaire were largely
ost-menopausal with 40% of them being obese (defined
ith a body mass index 30 kg/m2) (Table 1). Cardiac risk
actors were prevalent with more than half of women being
ypertensive and hyperlipidemic. A majority of the 914
omen had 50% stenosis at coronary angiography. The
ubset undergoing exercise stress testing was similar in terms
f risk factors and coronary disease extent, although they
ere slightly younger with an average age of 56  10 years
s compared to the overall group.
ASI and exercise testing MET results. On average,
omen exercised for 5.7 3 min or 6 3 METs (Table 1).
nly 12% of women achieved9.9 METs during treadmill
xercise while nearly two-thirds of women achieved 85%
able 2. Clinical Characteristics of the 251 Women by Exercise
% or Mean  SD Values
(Where Indicated)
1–4.7 METs
(n  75)
ge (yrs)* 60  10
ostmenopausal* 81%
ody mass index 32  7
30 kg/m2 56%
hest pain†
Nonanginal 27%
Atypical 37%
Typical 36%
ardiac risk factors
Hypertension* 68%
Current smoker 20%
Diabetes† 29%
Insulin-dependent 17%
Hypercholesterolemia 53%
oronary disease extent‡
No stenosis 50% 59%
1-vessel coronary disease 11%
2-vessel coronary disease 17%
3-vessel coronary disease 13%
xercise test results
Peak heart rate (beats/min)* 131  22
85% predicted max heart rate* 54%
Peak systolic blood pressure (mm Hg) 169  27
Exertional chest pain 34%
ST-segment depression 1.0 mm‡ 18%
Number of abnormal leads‡ 1.0  2
Max ST-segment depression‡ (mm) 0.4  0.7
p  0.001; †p  0.05; ‡p  0.01.
METs  metabolic equivalents.redicted maximal heart rate. During exercise testing, 27% of women reported chest pain symptoms. Myocardial isch-
mia, documented by ST-segment depression 1.0 mm,
as reported in 41% of women.
Women who had lower peak METs were generally older,
ostmenopausal, obese, had more typical angina, hyperten-
ive, diabetic, hypercholesterolemic, and had a greater prev-
lence of obstructive coronary disease at coronary angiogra-
hy (Table 2). As expected, higher peak heart rates and a
reater frequency of 85% predicted maximum heart rate
ere observed in women with higher MET capacity during
readmill exercise.
When compared with the entire cohort of 914 women
Table 3), exercising patients were younger with a generally
ower cardiac risk factor profile. However, a similar pattern
cross the MET categories was observed when compared
ith the exercising subset. That is, patients with higher
ASI scores were younger, with a lower body mass index,
ore likely to have atypical or non-anginal chest pain, less
ikely to have cardiac risk factors, and to have more
revalent non-obstructive coronary disease at angiography.
ASI scores. Self-reported DASI scores revealed that
2%, 18%, 11%, and 19% women estimated their MET
apacity at 1 to 4.7, 4.8 to 7.4, 7.5 to 9.9, and 9.9,
espectively (Table 1). Of the women who reported
apabilities of performing 4.7 METs of work during
ousehold chores and recreational activities, they more
ng Measures of METs
4.8–7.4 METs
(n  113)
7.5–9.9 METs
(n  34)
>9.9 METs
(n  29)
58  10 51  10 49  9
77% 56% 41%
29  7 29  6 28  6
40% 38% 31%
31% 59% 45%
36% 29% 38%
33% 12% 17%
43% 38% 24%
20% 32% 21%
14% 12% 7%
5% 6% 3%
46% 44% 32%
70% 65% 90%
12% 18% 3%
11% 15% 3%
7% 2% 0%
148  18 152  17 160  16
59% 90% 98%
168  28 170  23 174  24
40% 13% 12%
55% 19% 8%
2.3  3 2.6  3 1.4  3
0.9  1 1.0  1.1 0.6  0.9Testiften had typical angina, more often were current smok-
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Functional Disability in Symptomatic Women February 7, 2006:36S–43Srs, diabetic, hypercholesterolemic, or had a family his-
ory of premature coronary disease. Additionally, women
ho reported higher DASI-estimated METs were less
ikely to have obstructive coronary disease at coronary
ngiography.
ASI-estimated prognosis. A total of 92 of the 914
omen experienced death or non-fatal myocardial infarc-
ion during five years of follow-up (Fig. 1). Overall, event-
igure 1. Death or myocardial infarction-free survival by Duke Activity Sta
able 3. Clinical Characteristics of the 914 Women by Duke Ac
% or Mean  SD Values
(Where Indicated)
1–4.7 METs
(n  472)
ge* 59  12
ostmenopausal 76%
ody mass index* 31  7
30 kg/m2 47%
hest pain*
Nonanginal 28%
Atypical 38%
Typical 34%
ardiac risk factors
Hypertension* 65%
Current smoker 22%
Diabetes† 32%
Insulin-dependent* 14%
Hypercholesterolemia† 62%
oronary disease extent*
No stenosis 50% 57%
1-vessel coronary disease 18%
2-vessel coronary disease 12%
3-vessel coronary disease 13%
p  0.01; †p  0.001,
METs  metabolic equivalents.tage cutpoints (n  914). Five-year survival corresponds to 95%, 92%, 88%, an
p  0.009).ree survival was significantly different by the extent of
oronary disease at angiography. Five-year rates of death or
yocardial infarction were 7%, 18%, 27%, and 34% for
ero-, one-, two-, and three-vessel coronary disease, respec-
ively (p  0.0001).
Cox proportional hazard event-free survival analysis re-
ealed that DASI-estimated METs was independently
redictive of death or myocardial infarction (p  0.009).
dex measurements of metabolic equivalents (METs), using Bruce protocol
Status Index Estimated METs
.8–7.4 METs
(n  168)
7.5–9.9 METs
(n  103)
>9.9 METs
(n  171)
59  12 60  11 55  10
78% 81% 66%
29  6 29  7 28  5
41% 41% 34%
38% 43% 43%
32% 32% 36%
30% 25% 21%
57% 50% 51%
19% 18% 15%
21% 15% 14%
13% 6% 6%
56% 44% 41%
57% 70% 78%
20% 15% 11%
17% 5% 5%
6% 10% 7%tus Intivity
4d 85% for 9.9, 7.5 to 9.9, 4.8 to 7.4, and 1 to 4.7 METs, respectively
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February 7, 2006:36S–43S Functional Disability in Symptomatic Womenvent-free survival was 95%, 92%, 88%, and 83% for METs
f 9.9, 7.5 to 9.9, 4.8 to 7.4, and 1 to 4.7, respectively (p
0.009). Relative risk ratios were elevated 1.9-, 2.1-, and
.7-fold for women with estimated DASI MET scores of
.5 to 9.9, 4.8 to 7.4, and 1 to 4.7, respectively, when
ompared with those scoring 9.9 METs (p  0.009).
verall 67% of all deaths or myocardial infarction occurred
n women whose DASI METs were 4.7 (p  0.003).
In a risk-adjusted analysis, the DASI remained an inde-
endent estimator of death or myocardial infarction (p 
.015), even after controlling for age, body mass index,
iabetes, hypertension, hyperlipidemia, history of coronary
isease, and the extent of coronary disease at angiography.
pecifically, in this risk-adjusted model, every unit increase
n the DASI MET subsets of 4.8 to 7.4, 7.4 to 9.9, and
9.9 was associated with a 25% (95% confidence interval
% to 40%) decrease in death or myocardial infarction when
ompared to women with DASI MET values 4.7 (p 
.015).
ncidence of indeterminate exercise testing results by
ASI scores. Of the women who reported an estimated
ASI of 4.7 METs (n  108), an inability to achieve
redicted maximal heart rate was noted in 37%, and
tress-induced ischemia was observed in 39% (p  0.0001)
Table 4). For women with DASI estimates of 4.7 METs
n  143), only 6% failed to achieve peak maximal stress
evels, and 30% did not exhibit electrocardiographic isch-
mia (p  0.0001). Similar results were noted using a
utpoint of 6 and 6 or 3 and 3 METs (p  0.021
nd p  0.001).
rognosis by exercise and DASI METs. Of the 251
omen that had both exercise test and DASI MET
easurements, there were a total of 73 cardiac events
bserved over five years of follow-up (Fig. 2). This included
4 admissions for unstable angina, 4 myocardial infarctions,
1 admissions for heart failure, 9 strokes, and 13 deaths.
rom the exercise test, estimated METs levels from4.7 to
9.9 were associated with annualized risk-adjusted event
ates ranging from 7.2% to 1.8% (p 0.007) (Fig. 2). These
esults were similar to the event rates noted with estimated
ASI MET levels (p  0.0001).
Of the 40 women who failed to achieve 85% predicted
aximum heart rate, five-year event-free survival was 52%
Table 4. Rates of Ischemia and Indeterminate
Heart Rate) by DASI Measurements of MET
MET Category
No Ischemia
(n  70)
3 METs (n  62) 28%
3 METs (n  189) 27%
4.7 METs (n  108) 24%
4.7 METs (n  143) 30%
6 METs (n  141) 21%
6 METs (n  110) 34%
DASI  Duke Activity Status Index; METs  metabolic es compared to 77% for the 220 women achieving adequate
a
eeart rate levels (p  0.005). Approximately 63% of the
vents occurred in women with4.7 METs on DASI (p
.0001), compared to only 28% of women with significant
T-segment depression (p  0.011).
ISCUSSION
he current results support the value of the DASI-
stimated MET functional capacity as an added guide to
iagnostic decision making in women presenting with signs
nd symptoms suggestive of myocardial ischemia. The
ASI is a short, easily administered questionnaire of
elf-reported activities of daily living used to estimate
aximal oxygen consumption and, in this case, to provide
nsight into their likelihood of major adverse cardiac events
7,11–20). Although recent work has documented the
rognostic value of exercise capacity in women (5,6), the
urrent results suggest that application of the DASI might
e used alternatively to easily and economically identify
t-risk symptomatic women (20–23). The use of the DASI
ay be particularly helpful, as a pre-test risk assessment
ool, for the large subset of women less capable of perform-
ng maximal levels of exercise stress, including those with
igure 2. Annualized total cardiovascular event rates by exercise stress
esting and Duke Activity Status Index (DASI)-estimated metabolic
quivalents (METs) in 251 symptomatic women. p  0.007 for exercise
Results (i.e., 85% Predicted Maximum
schemia
 142)
Indeterminate
Results
(n  39) p Value
40% 32% 0.001
63% 10%
39% 37% 0.0001
64% 6%
59% 20% 0.021
56% 10%
ents.Test
s
I
(nnd p  0.0001 for DASI based upon the univariable Cox model for
xercise and DASI METs.
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urther insight into their event risk (20–23).
From the WISE study, women who report functional
mpairment on the DASI (i.e.,4.7 METs) were less likely
o exhibit myocardial ischemia and more likely to have
ndeterminate stress test results (i.e., failure to achieve 85%
redicted maximum heart rate). As these women with
nadequate heart rate responses to exercise have worsening
vent-free survival, including more hospitalizations for acute
yocardial infarction or death, when compared to women
chieving adequate stress levels, the current results suggest
hat the DASI could be used before exercise stress testing in
ymptomatic women to improve identification of higher-
isk, functionally impaired subjects that might benefit from
harmacologic as opposed to exercise stress testing. This
trategy could foster reduced evaluation costs and improve
ime to diagnosis for women presenting for the evaluation of
hest pain symptoms. It should also be noted that the
urrent exercise testing guidelines support referral to phar-
acologic stress testing in patients with submaximal exer-
ise capacity (4).
he impact of functional capacity on prognosis in
omen. Functional capacity is one of the strongest and
ost consistent estimators of cardiac prognosis in women
nd men (4). Exercise capacity is also strongly associated
ith all-cause mortality for both genders (18,19). In the
ecent American College of Cardiology/American Heart
ssociation guidelines for exercise testing, treadmill stage,
xercise duration, exercise capacity, peak watts, and METs
ere all significant independent predictors of an adverse
utcome (4). In particular, failure to achieve 5 METs during
readmill exercise is associated with worsening prognosis in
ultiple reports (3–6). In two recent cohorts of asymptom-
tic women, all-cause survival was 98% at 9 years (5) but
ecreased to 65% at 20 years (6) among the women who
chieved 5.5 METs on exercise testing. From the current
eries of symptomatic women, event-free survival at five
ears ranged from 83% to 95% for estimated METs ranging
rom4.7 to9.9 using the self-reported DASI. Similarly,
n a report comprising 147 post-myocardial infarction and
59 coronary bypass surgery patients, functional status at
hree months was one of the main determinants of recovery
t one year (16). In our subset of 251 women undergoing
xercise stress testing, a similar ability to risk stratify was
oted for exercise and DASI MET measurements.
Snader and colleagues (24) examined the prognostic value
f estimated functional capacity and thallium-201 single-
hoton emission computed tomography findings. Based
pon these findings in 3,400 patients, 57% of the deaths
ccurred in patients achieving 6 METs (p  0.0001).
rom the current series of 914 women, 67% of all deaths or
yocardial infarctions occurred in women with 4.7
ETs on DASI. Even when controlling for other factors,
air or poor functional capacity was associated with a
.4-fold (95% confidence interval: 1.6 to 12.0) higher rate of
ardiac mortality (p  0.004). In the current series, a peduced DASI score of 4.7 METs was associated with a
.7-fold higher relative risk of cardiac events when com-
ared to women with higher functional capabilities. Con-
istent with the current study examining electrocardio-
raphic stress results, the presence of single-photon
mission computed tomography perfusion defects in the
leveland Clinic series (24) was a less powerful estimator of
eath (adjusted relative risk [for each two defects] 1.2, 95%
onfidence interval: 1.03 to 1.4, p 0.02) as compared with
unctional capacity.
xercise testing in women. For women undergoing exer-
ise testing, it appears from our experience base and inter-
ctions with many clinicians that the short duration of
readmill exercise for women is often questioned as to
hether a sufficient observational period transpired for the
scertainment of coronary disease likelihood. Prior reports
25–29) and the current study results demonstrate that the
verage woman has an estimated MET capacity of 5.5 to 6.0
ETs. For many women, undergoing common exercise
tress testing protocols, such as the Bruce (or modified)
rotocol, where the first few minutes of exercise require 3 to
.7 METs of work, premature peripheral fatigue may
reempt achievement of an adequate level of stress. This
upposition is supported by our results revealing a higher
ate of indeterminate results and less inducible ischemia for
omen with self-reported low DASI scores. Nearly one-
hird of our women who exhibited functional impairment
i.e., 4.7 DASI METs) failed to achieve target heart rates
uring exercise stress testing.
The recent American College of Cardiology/American
eart Association stable angina guidelines delineate deci-
ions regarding the use of exercise or pharmacologic stress
esting as determined by a patient’s ability to exercise (26).
s most household chores require approximately 4 METs
f work (4), the self-reported DASI results could be used to
ore precisely guide optimal test choice in women and men.
pecifically, women with impaired (i.e., 4.7 METs) aer-
bic capacity should be considered for pharmacologic stress
maging. Nearly two-thirds of cardiovascular events oc-
urred in women whose DASI MET level was 4.7 as
ETs compared to only 28% of poor outcomes occurring
n women with an abnormal ST-segment response, suggest-
ng that the DASI could be used as an indicator of global
isk status for targeted risk management. The DASI could
lso provide complementary prognostic information for the
ore than two million women who undergo pharmacologic
tress testing every year (27).
tudy limitations. Although we present data prospectively
ollected from a multicenter registry, additional validation
f the current study results is needed; validation of these
esults will be important in non-catheterized populations.
owever, the included patient series appears typical for
t-risk women evaluated with suspected myocardial isch-
mia, and the results should be generally applicable to
ypical stress laboratory populations (25). In addition to the
rognostic value of functional capacity, recent data suggest
t
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February 7, 2006:36S–43S Functional Disability in Symptomatic Womenhat measures of heart rate recovery could further risk
tratify female cohorts (30). However, at the time of design
or the WISE study, these data were not available, and,
herefore, heart rate recovery measurements were not
ollected.
onclusions. The current results support prior evidence
eporting that women with suspected myocardial ischemia
ften have impaired functional capacity and are at increased
isk of cardiac events. The DASI, a simple and inexpensive
uestionnaire that takes 5 to 8 min to administer and score,
orrelates with a woman’s capabilities to perform adequate
evels of exercise stress testing and predicts prognosis to a
imilar degree. Based upon the current results, if applied
rospectively, administration of the DASI may improve
dentification of higher-risk women for diagnostic pharma-
ologic stress testing and targeted risk management to
mprove prognosis.
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PPENDIX
or the DASI questionnaire and scoring, please see the
nline version of this article.
